Elevated IRT levels in African-American infants: Implications for newborn screening in an ethnically diverse population

Pediatric Pulmonology

Volumn 43, Issue 7, 2008, Pages 638-641

  Giusti, Robert ^a,l   Comber, P ^b   Germana, J ^c   Ting, A ^d   Quittell, L ^e   Berdella, M ^f   Ren, C ^g   Kier, C ^h   Anbar, R ⁱ   Boyer, J ^j   Caggana, M ^k  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c Schneider's Children's Hospital

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e Children's Hospital of New York   (United States)

^f CATHOLIC MEDICAL CENTER   (United States)

^g STRONG MEMORIAL HOSPITAL   (United States)

^h STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

ⁱ SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^j Maria Fareri Children's Hospital   (United States)

^k WADSWORTH CENTER   (United States)

^l NONE   (United States)

more..

Author keywords

Cystic fibrosis; Immunoreactive trypsinogen; Newborn screen

Indexed keywords

CHLORIDE; IMMUNOREACTIVE TRYPSINOGEN; TRYPSINOGEN;

AFRICAN AMERICAN; ARTICLE; ASIAN; BLOOD LEVEL; CAUCASIAN; CYSTIC FIBROSIS; ETHNIC GROUP; FALSE POSITIVE RESULT; GENE MUTATION; HISPANIC; HUMAN; IMMUNOREACTIVITY; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SCREENING TEST; SWEAT;

AFRICAN AMERICANS; CYSTIC FIBROSIS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MASS SCREENING; PREDICTIVE VALUE OF TESTS; RISK; TRYPSINOGEN;

EID: 46849086377     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20824     Document Type: Article

References (15)

1. Crossley JR, Elliot RB, Smith PA. Dried blood spot screening for cystic fibrosis in the newborn. Lancet 1979;i:472-474.
2. IMMUCHEM™ Blood Spot Trypsin-MW Elisa, MP Biomedicals, www.mpbio.com.
3. Giusti R, Badgwell A, Iglesias AD. New York State Cystic Fibrosis Consortium: the First 2.5 years of experience with cystic fibrosis newborn screening in an ethnically diverse population. Pediatrics 2007;119:e460-e467.
4. Macek M Jr, Mackova A, Hamosh A, Hilman BC, Selden RF, Lucotte G, Friedman KJ, Knowles MR, Rosenstein BJ, Cutting GR. Cystic Fibrosis in African Americans. Am J Hum Genet 1977;60:1122-1127.
5. Rock MJ, Mischler EH, Farrell PM, et al. Immunoreactive Trypsinogen screening for Cystic Fibrosis: characteristics of infants with false positive screening test. Pediatr Pulm 1989;6:42-48.
6. Gregg RG, Simantel A, Farrell PM, Koscik R, Kosorok MR, Laxova A, Laessig RH, Hoffman G, Hassemer D, Mischler EH, Splaingard M. Newborn screening for cystic fibrosis in Wisconsin: comparison of Biochemical and Molecular methods. Pediatrics 1997;99:819-824.
7. Kosorok MR, Wei WH, Farrell PM. The incidence of Cystic Fibrosis. Stat Med 1996;15:449-462.
8. Cheillan D, Vercherat M, Chevalier-Porst F, Charcosset M, Rolland MO, Dorche C. False-positive results in neonatal screening for cystic fibrosis based on a three-stage protocol (IRT/DNA/IRT): should we adjust IRT cut-off to ethnic origin? J Inherit Metab Dis 2005;28:813-818.
9. Rock MJ, Hoffman G, Laessig RH, Kopish GJ, Litsheim TJ, Farrell PM. Newborn Screening for Cystic Fibrosis in Wisconsin: nine-year experience with routine trypsinogen testing. J Pediatr 2005;147:S73-S77.
10. Herson VC, LaFreniere J. Elevated Immunoreactive Trypsinogen (IRT) in premature infants Pediatric Pulmonary Supplement, 19 September 1999; p. 214, Thirteenth North American Cystic Fibrosis Conference.
11. Ravine D, Francis RI, Danks DM. Non-specific elevation of immunoreactive trypsinogen in sick infants. Eur J Pediatr 1993;152:346-349.
12. Kiska Z, Palomar L, Lee KA. Racial disparity in the frequency of recurrence of preterm birth. Am J Obstet Gynecol 2007;196:131.e1-131.e6.
13. New York State Department of Health Vital Statistics and Minority Health Surveillance Report, September 2007.
14. Heim RA, Sugarman EA, Alitto BA. Improved detection of Cystic Fibrosis mutations in the heterogeneous U.S. population using an expanded, pan ethnic mutation panel. Genet Med 2001;3:168-176.
15. Rock MJ, Mischler EH, Farrell PM, Wei Lee-Jen, Bruns W Theodore, Hassemer DJ, Laessig RH. Newborn Screening for Cystic Fibrosis Is Complicated by age-related decline in Immunoreactive Trypsinogen Levels. Pediatrics 1990;85:1001-1007.